Search

You searched for "OCT"

1580 results found

NEOS (North of England Ophthalmological Society) Summer Meeting (Wetherby 19)

4 June 2019 | Ophthalmology
By Ritu Chaturvedi, ST5, Northwest Deanery. The North of England Ophthalmological Society (NEOS) summer meeting 2019 was convened by Andy Chung, Pinderfields Hospital, and the main theme was ‘Beyond excellence in ophthalmology’. An engaging programme attracted a good attendance and...

DISC lens slow myopia progression in Hong Kong Chinese schoolchildren

1 April 2014 | | Ophthalmology, Paediatric Ophthalmology / Strabismus | Child Health (Paediatrics), Clinical Trial, Contact Lens, Optics and Refraction
This is a prospective double-blind randomised trial between September 2007 and October 2009. It included 221 children aged 8-13 years, with myopia between -1 and -5 Dioptres ≤1.00D. There were 111 patients in the defocus incorporated soft contact DISC group...

Clinical evaluation of a multifocal aspheric diffractive intraocular lens

1 February 2014 | | Cataract and Refractive | Lens and zonules, Optics and Refraction, Treatment Surgery
This is a multi-centre prospective study involving five different centres in Europe including 52 patients with cataract. The average age was 68.5±10.5 years, 35 females were bilateral implanted with aspheric diffractive multifocal lens implantation of the Tecnis 1-Piece multifocal intraocular...

Culture positivity of needles for IVT injections

1 December 2013 | | Retina / Uvea / Vitreous
Given the worldwide use of intravitreal (IVT) injections, the authors of this paper set out to evaluate the rate of culture positivity of the needles used in routine IVT injections and compare this positivity between 27-gauge and 30-gauge needle tips....

Moorfields Eye Charity appoints Dr Louise Wood CBE as new chair

3 June 2024 | Louise Wood, Moorfields, Industry, infrastructure, charity, hospital, grants, Appointments
Dr Louise Wood CBE has been appointed as Moorfields Eye Charity’s new chair and will succeed Mervyn Walker when he steps down from the role in July 2024.

The original smooth operator: Sir Robin Millar

4 December 2023 | | Genetics
As an early 80s kid, if you lacked sufficient pocket money, building a music collection entailed recording your favourite songs off the radio with a cassette deck and hoping the presenter didn’t interrupt at any point, with a finger hovering...

Robotic assisted orbital surgery (RAOS) – a novel approach to orbital malignancy surgery

3 June 2024 | | Ophthalmology, Orbit, Oculoplastics
Robotic technology in ENT surgery has been used in certain areas of head and neck cancer care but, in this article, we hear of an exciting development from the team at Guy’s & St Thomas’. Advances in surgical robotic technology...

Kabgayi International Ophthalmology Conference 2024

16 February 2024
by Michael Mikhail, FRCOphth, Consultant Ophthalmologist; Vitreoretinal Surgeon, Kabgayi Eye Unit, Rwanda. My journey to Rwanda in April 2022 aimed to expand vitreoretinal services, but it also highlighted the need for robust scientific discourse, akin to the UK's ophthalmology culture,...

Haag-Streit Academy launches exciting new agenda for their ‘Improving Outcomes’ Biometry courses

25 June 2024 | Research & Development, Company Profiles, Awards, Conferences & Anniversaries
Haag-Streit Academy are thrilled to announce the launch of a new agenda for their highly popular ‘Improving Outcomes’ Biometry courses.

GOC approves SPOKE Project 5 output

28 June 2024 | GOC, ABDO, Optometry, opticians, optometrist
The General Optical Council (GOC) has approved the fifth output of the Sector Partnership for Optical Knowledge and Education (SPOKE). The output is now available to download from the College of Optometrists website.

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...